IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	39.94 (50)
Ask (Size)	39.95 (15)
Prev. Close	39.95
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	104,009,398
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

Performance

More News

IVERIC bio Inc. (NASDAQ: ISEE) Records 52-Week High Thursday Morning

July 06, 2023

Via Investor Brand Network

IVERIC bio Inc. (NASDAQ: ISEE) Making Surprising Moves in Monday Session

June 05, 2023

Via Investor Brand Network

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 05, 2023

From IVERIC bio, Inc.

Via Business Wire

IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE

June 14, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 02, 2023

From IVERIC bio, Inc.

Via Business Wire

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Via Investor's Business Daily

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?

June 01, 2023

Via TheNewswire.com

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?

June 01, 2023

Via News Direct

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? ↗

May 30, 2023

Via Benzinga

Why Shares of Annexon Are Plummeting Thursday ↗

May 25, 2023

Via The Motley Fool

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 24, 2023

From IVERIC bio, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗

May 04, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 ↗

May 03, 2023

Via Benzinga

IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE

May 02, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗

May 02, 2023

Via Benzinga

Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today ↗

May 01, 2023

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq – ISEE), Midwest Holding Inc. (Nasdaq – MDWT), Hoth Therapeutics, Inc. (Nasdaq – HOTH)

May 01, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 ↗

May 01, 2023

Via Benzinga

Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma ↗

May 01, 2023

Via Investor's Business Daily

First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories ↗

May 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 01, 2023

Via Benzinga

Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move ↗

May 01, 2023

Via Benzinga

Frequently Asked Questions

Is IVERIC bio, Inc. - Common Stock publicly traded?

Yes, IVERIC bio, Inc. - Common Stock is publicly traded.

What exchange does IVERIC bio, Inc. - Common Stock trade on?

IVERIC bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for IVERIC bio, Inc. - Common Stock?

The ticker symbol for IVERIC bio, Inc. - Common Stock is ISEE on the Nasdaq Stock Market